SEDI Insider filing browser
Filter by Company
×
Filter by $CAD Amount
×
Filter by Filing Type
Filter by Insider
×
 
Date Issuer Insider Transaction Amount New Balance ⓘ
The balance of securities held by registered holder at the time of the transaction. Insiders may direct multiple registered holders and hold multiple security types.
Filed 2020-05-25 21:02
Tx date 2020-05-22
$APC
Advanced Proteome Therapeutics Corporation
Krantz, Benjamin Alexander
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
Warrants
16 - Acquisition or disposition under a prospectus exemption

+1,098,713 vol
1,098,713
Filed 2020-05-24 17:44
Tx date 2020-05-22
$APC
Advanced Proteome Therapeutics Corporation
Krantz, Benjamin Alexander
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
Warrants
16 - Acquisition or disposition under a prospectus exemption

+1,098,713 vol
Filed 2020-05-24 18:24
Tx date 2020-05-19
$APC
Advanced Proteome Therapeutics Corporation
Krantz, Benjamin Alexander
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
Common Shares
97 - Other
$4,468
+89,372 vol
$0.05 each
89,372
Filed 2020-05-24 17:44
Tx date 2020-05-22
$APC
Advanced Proteome Therapeutics Corporation
Krantz, Benjamin Alexander
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
Warrants
16 - Acquisition or disposition under a prospectus exemption

+1,098,713 vol
1,098,713
Filed 2020-05-24 17:42
Tx date 2019-01-14
$APC
Advanced Proteome Therapeutics Corporation
Krantz, Benjamin Alexander
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
Warrants
00 - Opening Balance-Initial SEDI Report
Filed 2020-05-24 17:39
Tx date 2020-05-22
$APC
Advanced Proteome Therapeutics Corporation
Krantz, Benjamin Alexander
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
Common Shares
16 - Acquisition or disposition under a prospectus exemption
$65,922
+1,098,713 vol
$0.06 each
1,198,713
Filed 2020-05-24 17:39
Tx date 2020-05-19
$APC
Advanced Proteome Therapeutics Corporation
Krantz, Benjamin Alexander
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
Common Shares
97 - Other

+100,000 vol
Filed 2020-05-24 17:39
Tx date 2020-05-19
$APC
Advanced Proteome Therapeutics Corporation
Krantz, Benjamin Alexander
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
Common Shares
97 - Other

+100,000 vol
100,000
Filed 2020-05-24 17:37
Tx date 2019-01-14
$APC
Advanced Proteome Therapeutics Corporation
Krantz, Benjamin Alexander
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
Common Shares
00 - Opening Balance-Initial SEDI Report